PROCTER & GAMBLE HEALTH | SMRUTHI ORGANICS | PROCTER & GAMBLE HEALTH/ SMRUTHI ORGANICS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 63.6 | 54.4% | View Chart |
P/BV | x | 10.6 | 2.6 | 409.7% | View Chart |
Dividend Yield | % | 2.0 | 1.3 | 154.2% |
PROCTER & GAMBLE HEALTH SMRUTHI ORGANICS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
SMRUTHI ORGANICS Mar-23 |
PROCTER & GAMBLE HEALTH/ SMRUTHI ORGANICS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 279 | 1,926.6% | |
Low | Rs | 3,883 | 111 | 3,499.8% | |
Sales per share (Unadj.) | Rs | 740.7 | 123.2 | 601.3% | |
Earnings per share (Unadj.) | Rs | 138.2 | 3.6 | 3,831.5% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 7.6 | 2,041.4% | |
Dividends per share (Unadj.) | Rs | 95.00 | 2.00 | 4,750.0% | |
Avg Dividend yield | % | 2.1 | 1.0 | 200.0% | |
Book value per share (Unadj.) | Rs | 447.6 | 59.5 | 752.0% | |
Shares outstanding (eoy) | m | 16.60 | 11.45 | 145.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.6 | 395.0% | |
Avg P/E ratio | x | 33.5 | 54.0 | 62.0% | |
P/CF ratio (eoy) | x | 29.8 | 25.6 | 116.4% | |
Price / Book Value ratio | x | 10.3 | 3.3 | 315.9% | |
Dividend payout | % | 68.7 | 55.4 | 124.0% | |
Avg Mkt Cap | Rs m | 76,761 | 2,229 | 3,443.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 158 | 1,302.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 1,410 | 871.8% | |
Other income | Rs m | 184 | 1 | 17,186.9% | |
Total revenues | Rs m | 12,480 | 1,411 | 884.2% | |
Gross profit | Rs m | 3,247 | 98 | 3,319.5% | |
Depreciation | Rs m | 281 | 46 | 614.6% | |
Interest | Rs m | 8 | 8 | 93.6% | |
Profit before tax | Rs m | 3,142 | 45 | 6,991.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 4 | 23,341.6% | |
Profit after tax | Rs m | 2,295 | 41 | 5,554.8% | |
Gross profit margin | % | 26.4 | 6.9 | 380.8% | |
Effective tax rate | % | 27.0 | 8.1 | 334.0% | |
Net profit margin | % | 18.7 | 2.9 | 637.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 667 | 1,756.0% | |
Current liabilities | Rs m | 6,791 | 369 | 1,841.5% | |
Net working cap to sales | % | 40.0 | 21.1 | 189.3% | |
Current ratio | x | 1.7 | 1.8 | 95.4% | |
Inventory Days | Days | 263 | 3 | 7,776.0% | |
Debtors Days | Days | 343 | 957 | 35.9% | |
Net fixed assets | Rs m | 10,617 | 403 | 2,631.9% | |
Share capital | Rs m | 166 | 114 | 145.0% | |
"Free" reserves | Rs m | 7,265 | 567 | 1,281.0% | |
Net worth | Rs m | 7,431 | 682 | 1,090.2% | |
Long term debt | Rs m | 0 | 6 | 0.0% | |
Total assets | Rs m | 22,330 | 1,070 | 2,086.1% | |
Interest coverage | x | 409.1 | 6.5 | 6,332.8% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.6 | 1.3 | 41.8% | |
Return on assets | % | 10.3 | 4.6 | 222.8% | |
Return on equity | % | 30.9 | 6.1 | 509.5% | |
Return on capital | % | 42.4 | 7.7 | 548.1% | |
Exports to sales | % | 0 | 35.7 | 0.0% | |
Imports to sales | % | 13.1 | 27.4 | 47.6% | |
Exports (fob) | Rs m | NA | 504 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 387 | 415.3% | |
Fx inflow | Rs m | 1,465 | 504 | 290.8% | |
Fx outflow | Rs m | 1,605 | 387 | 415.3% | |
Net fx | Rs m | -140 | 117 | -119.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 121 | 1,949.6% | |
From Investments | Rs m | -215 | -102 | 209.9% | |
From Financial Activity | Rs m | -985 | -15 | 6,486.8% | |
Net Cashflow | Rs m | 1,160 | 3 | 33,926.9% |
Indian Promoters | % | 0.0 | 63.8 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 0.0 | - | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 36.2 | 133.2% | |
Shareholders | 56,778 | 5,877 | 966.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | SMRUTHI ORGANICS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -1.10% | 0.45% |
1-Month | -1.15% | 5.98% | 2.55% |
1-Year | 0.73% | 12.13% | 56.14% |
3-Year CAGR | -8.76% | -14.57% | 15.22% |
5-Year CAGR | 4.97% | 22.92% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the SMRUTHI ORGANICS share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of SMRUTHI ORGANICS the stake stands at 63.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of SMRUTHI ORGANICS.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
SMRUTHI ORGANICS paid Rs 2.0, and its dividend payout ratio stood at 55.4%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of SMRUTHI ORGANICS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.